Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.
The Scientist
Most Recent
A male hormone-blocker currently used to treat prostate cancer may also benefit breast cancer patients.
A new report suggests that potential malaria treatments currently under study comprise the largest drug pipeline in history.
Revising a dysfunctional gene in vivo for the first time, researchers successfully restore blood clotting in hemophiliac mice.
The virulent stain that has killed 48 people produces Shiga toxin and sticks to the intestinal wall.
Two new approaches to test bone density provide a simpler way to predict risk of osteoporosis.
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
An HPV vaccination program in Australia appears to have resulted in a drop in cervical lesions among young women
Humane Society accuses a panel tasked with deciding the fate of retired chimpanzees of monkey business
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
